| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7511242 | International Journal of Drug Policy | 2018 | 7 Pages |
Abstract
Our results show that while MSI use fewer stimulants, they have more HIV/HCV risk practices than other injectors. However, when MSI are prescribed morphine sulfate as a treatment, these practices tend to decrease. Our findings suggest the importance of increasing access to morphine sulfate as a new OST in France.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Perrine Roux, Salim Mezaache, Laélia Briand-Madrid, Marie Debrus, Nicolas Khatmi, Gwenaelle Maradan, Camélia Protopopescu, Daniela Rojas-Castro, Patrizia Carrieri,